-
With the planned disposal of a further $240mn of Ebitda, the parties are showing their commitment to closing the overall deal. -
Listed composite insurer American National has been placed up for sale and may attract carve-up interest.
-
Chubb discipline, Hartford reluctance and investor lassitude combine to impede a transaction.
-
With a sale of the remedy assets to AJG not yet agreed, the firms will have to choose their words carefully this week.
-
Long hold periods could intensify the pressure on smaller PE-backed retail brokers.
-
This week, we revealed that Aon/Willis Towers Watson are looking to separately divest a block of Willis' European businesses and Willis Re, as they work to get their mega merger approved by regulators in the face of competition concerns.
-
The rejection was inevitable although the emphatic nature of it hints at a real determination to remain independent.
-
Independent agency distribution remains incredibly robust, despite the Covid-19 pandemic and the emergence of direct-to-consumer InsurTechs.
-
The broker upgraded its Q1 outlook with more optimism on later quarters, and increased confidence on margins and M&A.
-
As yet, the European Commission (EC) has not produced a formal State of Objections to Aon's proposed takeover of Willis Towers Watson following the Phase II competition probe it began in December.
-
The deal leaves Amwins, RSG and CRC with a market share of more than 80%, and it will be hard for anyone else to break in.
Most Recent
